May 11, 2025, 01:11

LCRF Research Grant on Overcoming Resistance in Lung Cancer

This Lung Cancer Research Foundation (LCRF) grant supports research aimed at understanding and overcoming resistance to therapies in lung cancer. Eligible projects include mechanistic studies, novel treatment strategies, and the development of diagnostic tools or biomarkers. The focus includes various lung cancer subtypes and stages across the therapeutic continuum.

Eligibility:

Must be a postdoctoral researcher, clinical fellow, or early-/mid-career investigator (less than 10 years since initial faculty appointment)
Affiliated with a nonprofit academic or research institution
Open to U.S. and international applicants
Cannot have received LCRF funding in the past 4 years
Cannot apply to more than one LCRF funding stream in the same cycle

Funding:

Up to USD 150,000 over 2 years (USD 75,000 per year)
No indirect costs allowed
Travel and publication costs permitted
Salary support over 20% must be justified
Equipment costs must be limited and essential to the project

Deadline:

Full proposals due: June 2, 2025
Award notification: November 2025
Project start: December 1, 2025

More Information:

Application Portal – ProposalCentral

Contact: [email protected]

biomarkers cancer drug resistance immunotherapy LCRF Lung cancer OncoDaily Oncology oncology research targeted therapy therapy resistance translational science

FDA Grants Accelerated Approval for Telisotuzumab Vedotin (EMRELIS™) in c-MET–Overexpressing Advanced Non-Small Cell Lung Cancer

Oncologist Near Me – Wafik S. El-Deiry: A Global Leader in Translational Oncology and Cancer Research

In Memory of Bob Marley: His Battle with Melanoma and the Importance of Early Detection

Who From Oncology is Featured in TIME100 Health 2025?

FDA Announces Aggressive Timeline to Scale 1st AI-Assisted Scientific Review Pilot